Retraction: Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies

Juan Manuel Galdopórpora; María Victoria Olivera; Angelina Ibar; Darío Hernán Farriol; Martín Federico Desimone; Cynthia Melisa Melián Queirolo; Helena Pardo; María Victoria Tuttolomondo

doi:10.37349/eds.2025.100896

Open Access

Retraction

Retraction: Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies

Affiliation:

¹Unidad de Investigación en Bioquímica Traslacional y Metabolismo (UBiTyM), Facultad de Odontología, Universidad de Buenos Aires, CABA 1113, Argentina

Juan Manuel Galdopórpora ¹ ,

Affiliation:

²Universidad Nacional de Quilmes, Quilmes 1876, Argentina

María Victoria Olivera ² ,

Affiliation:

³Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CABA 1113, Argentina

Angelina Ibar ³ ,

Affiliation:

³Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CABA 1113, Argentina

Darío Hernán Farriol ³ ,

Affiliation:

⁴Departamento de Ciencias Químicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CABA 1113, Argentina ⁵Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET - Universidad de Buenos Aires, CABA 1113, Argentina

ORCID: https://orcid.org/0000-0002-0571-7962

Martín Federico Desimone ^4,5

Affiliation:

⁵Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET - Universidad de Buenos Aires, CABA 1113, Argentina ⁶Departamento de Sanidad, Nutrición, Bromatología y Toxicología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CABA 1113, Argentina

Cynthia Melisa Melián Queirolo ^5,6 ,

Affiliation:

⁷Centro NanoMat, Polo Tecnológico de Pando, Facultad de Química, Universidad de la República, Pando 15600, Uruguay

ORCID: https://orcid.org/0000-0002-0986-4580

Helena Pardo ⁷

Affiliation:

Email: mvt@ffyb.uba.ar; mvtuttolomondo@gmail.com

ORCID: https://orcid.org/0000-0003-3083-2919

María Victoria Tuttolomondo ^4,5*

Explor Drug Sci. 2025;3:100896 DOl: https://doi.org/10.37349/eds.2025.100896

Received: Accepted: Published: March 17, 2025

Retraction to “Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies” by Galdopórpora JM, Olivera MV, Ibar A, Farriol DH, Desimone MF, Queirolo CMM, et al. Explor Drug Sci. 2025;3:100895. DOI: 10.37349/eds.2025.100895

The original article has been retracted by the authors. After the article was published, concerns were raised by one of the authors regarding their prior consent to the submission. According to journal policy, the corresponding author is responsible for ensuring that all authors agree to the submission. The corresponding author was therefore contacted for clarification. The corresponding author acknowledged that prior consent for submission had not been obtained from some of the authors due to an internal miscommunication and misunderstanding within the authors’ research group, and requested the retraction of the article. Authors Darío Hernán Farriol, Martín Federico Desimone, and Cynthia Melisa Melián Queirolo agree with the decision to retract. Authors Juan Manuel Galdopórpora, María Victoria Olivera, Angelina Ibar, and Helena Pardo could not be reached as of publication.

This retraction was approved by the Editor-in-Chief.

Copyright: © The Author(s) 2025. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.